Type 1 Diabetes

For people living with type 1 diabetes and the clinicians and researchers who treat and study the disease, 2021 was a year of groundbreaking achievements and cause for optimism. Though as with any new experimental treatments, caveats abound.

A supplement of Vitamin D2 may improve insulin sensitivity and slow the increase of HbA1c for children and adolescents with new-onset type 1 diabetes, according to study findings published in the Journal of the Endocrine Society.

Pregnant women with type 1 diabetes and impaired hypoglycemia awareness have greater fear and more episodes of severe hypoglycemia than those with normal awareness, particularly in the first trimester, according to study data.

Among adults with type 1 diabetes, current tobacco users have worse diabetes-related outcomes vs. past users and those who have quit, according to study results published in Journal of Diabetes and Its Complications.

Intensive diabetes education with early initiation of continuous glucose monitoring is associated with improvements in HbA1c for children with type 1 diabetes, according to study data.

More snacking between meals, decreased physical activity and issues with sleep are among the adverse effects parents of children with type 1 diabetes reported with virtual school during the COVID-19 pandemic, according to study findings.

In this video exclusive, Caroline T. Nguyen, MD, talks with Sarit Polsky, MD, MPH, FAHA, about how to use continuous glucose monitoring for diabetes management during pregnancy.

Young children with type 1 diabetes had better time in range and lower mean HbA1c while using a hybrid closed-loop insulin delivery system compared with sensor-augmented insulin pump therapy, according to study data.

Closed-loop insulin pump therapy is associated with more time in range compared with sensor-augmented therapy among older adults with type 1 diabetes, according to study findings published in Diabetes Care.

The FDA has cleared the first tubeless hybrid closed-loop insulin delivery system for people with type 1 diabetes aged 6 years and older, according to a press release from Insulet.